Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US
Clinical trial NCT00847483 · COMPLETED
Trial details
- NCT number
- NCT00847483
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2002-08-01
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.